The Effects of Anlotinib Combined with Chemotherapy Following Progression on Cyclin-Dependent Kinase 4/6 Inhibitor in Hormone Receptor-Positive Metastatic Breast Cancer.

Ting Xu,Lili Zhang, Yuan, Sainan Hu,Min Dong, Xinyu Xu, Jiayuan Huang, Weili Xiong, Kexin Lou

JOURNAL OF CLINICAL ONCOLOGY（2024）

Cited 0|Views9

No score

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined